Anti-p53 [PAb421]
Cat# MBS488221-5x0,2mg
Size : 5x0.2mg
Brand : MyBiosource
p53 Recombinant Antibody – Monoclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS488221Recombinant monoclonal antibody to p53. Manufactured using Recombinant Platform with variable regions (i.e. specificity) from the hybridoma PAb421. More details
Product Overview
Online Datasheet in PDFProduct Name
p53, Recombinant Antibody
Full Product Name
Anti-p53 [PAb421]
Product Gene Name
p53 recombinant antibody
Product Synonym Names
Tumor suppressor p53; Cellular tumor antigen p53
Clonality
Monoclonal
Isotype
Mouse IgG2a, kappa
Clone Number
PAb421
Species Reactivity
Human, Monkey, Mouse, Rabbit, Rat
Purity/Purification
Purified
Protein A Affinity Purified
Protein A Affinity Purified
Specificity
Recognizes the mammalian mutant and wild-type p53 protein and reacts with anepitope between amino acid residues 370 and 378 (near the C-terminus of the protein).
Preparation and Storage
Store at 4 degree C for up to 3 months. For longer storage, aliquot and store at -20 degree C.
Molecular Weight
24,401 Da
OMIM
133239
Animal-free Manufacturing Platform
The recombinant antibody is manufactured using a recombinant, mammalian HEK293-based expression platform. The manufacturing platform is animal-free and animal component-free.
Immunogen
Synthetic peptide corresponding to aa 371-380 of human p53.
Antigen
p53
Antigen Description
Synthetic peptide corresponding to aa 371-380 of human p53.
Buffer Composition
PBS only with 0.02% Proclin 300.
Publication Note
Describes the production and subsequent characterisation of anti-p53 monoclonal antibody clones.
Product Categories/Family for p53 recombinant antibody
Cancer
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for p53 recombinant antibody
ELISA (EIA), Immunofluorescence (IF), Flow Cytometry (FC/FACS), In Vivo, Immunoprecipitation (IP), Western Blot (WB)
Product References and Citations for p53 recombinant antibody
Harlow E, Crawford LV, Pim DC, Williamson NM. J Virol. 1981 Sep;39(3):861-9. PMID: 6169844
Other Notes
Small volumes of p53 recombinant antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for p53 purchase
MBS488221 is a recombinant antibody targeting p53. Also known as Anti-p53 [PAb421]. Reactive in Human, Monkey, Mouse, Rabbit, Rat.
Additional Details
NCBI/Uniprot data below describe general gene information for p53. It may not necessarily be applicable to this product.
NCBI Official Full Name
P53
NCBI Official Synonym Full Names
tumor protein p53
NCBI Official Symbol
TP53
NCBI Official Synonym Symbols
P53; BCC7; LFS1; TRP53
UniProt Protein Name
Cellular tumor antigen p53
UniProt Synonym Protein Names
Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53
Protein Family
p53 and DNA damage-regulated protein
UniProt Gene Name
TP53
UniProt Synonym Gene Names
P53
NCBI Protein Information
cellular tumor antigen p53
NCBI Summary for p53
This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]
Show more UniProt Comments for p53
Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seem to have to effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492).
Show more Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with p53 recombinant antibody
| Reference Product | PubMed Publications |
|---|---|
| MDM2 recombinant antibody | >1210 publications with p53 and MDM2 |
| CDKN1A recombinant antibody | >927 publications with p53 and CDKN1A |
| CDKN2A recombinant antibody | >916 publications with p53 and CDKN2A |
| ATM recombinant antibody | >646 publications with p53 and ATM |
| BAX recombinant antibody | >612 publications with p53 and BAX |
| BCL2 recombinant antibody | >286 publications with p53 and BCL2 |
| MDM4 recombinant antibody | >137 publications with p53 and MDM4 |
| CDK2 recombinant antibody | >73 publications with p53 and CDK2 |
| CREBBP recombinant antibody | >35 publications with p53 and CREBBP |
| TP53BP2 recombinant antibody | >21 publications with p53 and TP53BP2 |
Pathways associated with p53 recombinant antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| AMP-activated Protein Kinase (AMPK) Signaling Pathway antibodies | AMP-activated Protein Kinase (AMPK) Signaling Pathway Diagram |
| ATM Signaling Pathway antibodies | ATM Signaling Pathway Diagram |
| Activation Of BH3-only Proteins Pathway antibodies | Activation Of BH3-only Proteins Pathway Diagram |
| Activation Of NOXA And Translocation To Mitochondria Pathway antibodies | Activation Of NOXA And Translocation To Mitochondria Pathway Diagram |
| Activation Of PUMA And Translocation To Mitochondria Pathway antibodies | Activation Of PUMA And Translocation To Mitochondria Pathway Diagram |
| Adaptive Immune System Pathway antibodies | Adaptive Immune System Pathway Diagram |
| Alzheimers Disease Pathway antibodies | Alzheimers Disease Pathway Diagram |
| Amyotrophic Lateral Sclerosis (ALS) Pathway antibodies | Amyotrophic Lateral Sclerosis (ALS) Pathway Diagram |
| Amyotrophic Lateral Sclerosis (ALS) Pathway antibodies | Amyotrophic Lateral Sclerosis (ALS) Pathway Diagram |
| Amyotrophic Lateral Sclerosis (ALS) Pathway antibodies | Amyotrophic Lateral Sclerosis (ALS) Pathway Diagram |
Diseases associated with p53 recombinant antibody
| Disease Name | Pubmed Publications |
|---|---|
| Carcinoma Antibodies | >4436 publications with p53 and Carcinoma |
| Breast Neoplasms Antibodies | >1700 publications with p53 and Breast Neoplasms |
| Colorectal Neoplasms Antibodies | >1095 publications with p53 and Colorectal Neoplasms |
| Carcinoma, Squamous Cell Antibodies | >1006 publications with p53 and Carcinoma, Squamous Cell |
| Glioma Antibodies | >827 publications with p53 and Glioma |
| Neoplasm Metastasis Antibodies | >721 publications with p53 and Neoplasm Metastasis |
| Sarcoma Antibodies | >600 publications with p53 and Sarcoma |
| Liver Neoplasms Antibodies | >597 publications with p53 and Liver Neoplasms |
| Cell Transformation, Neoplastic Antibodies | >588 publications with p53 and Cell Transformation, Neoplastic |
| Urologic Neoplasms Antibodies | >472 publications with p53 and Urologic Neoplasms |
Organs/Tissues associated with p53 recombinant antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >1506 publications with p53 and Blood |
| Lung Antibodies | >1364 publications with p53 and Lung |
| Brain Antibodies | >924 publications with p53 and Brain |
| Liver Antibodies | >752 publications with p53 and Liver |
| Bone Antibodies | >581 publications with p53 and Bone |
| Skin Antibodies | >473 publications with p53 and Skin |
| Lymph Node Antibodies | >470 publications with p53 and Lymph Node |
| Lymph Antibodies | >459 publications with p53 and Lymph |
| Bladder Antibodies | >394 publications with p53 and Bladder |
| Prostate Antibodies | >363 publications with p53 and Prostate |


